# Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)

> **NCT02450188** · PHASE4 · COMPLETED · sponsor: **University of Florence** · enrollment: 30 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Vardenafil
- **BEHAVIORAL:** CBST

## Key facts

- **NCT ID:** NCT02450188
- **Lead sponsor:** University of Florence
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02450188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02450188, "Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02450188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*